(DIANA-CDK-Panel)
The DIANA CDK Panel is an advanced selectivity profiling platform designed for drug discovery, enabling precise determination of dissociation constants (Kd) for inhibitor compounds across the complete set of all 20 Cyclin Dependent Kinases (CDKs). In addition, for several CDKs we provide multiple physiologically relevant cyclin bound variants, resulting in a uniquely comprehensive collection of 24 CDK/cyclin complexes.
This full family coverage is unmatched. DIANA Biotechnologies is the only provider offering all 20 CDKs for inhibitor profiling. Powered by our proprietary ultrasensitive DIANA assay, the panel ensures a wide dynamic range and reliable single well Kd quantification to support confident decision making in kinase inhibitor development
Download the full DIANA Kinase Inhibitor Profiling booklet here!
DIANA Technology Features
DIANA Technology: DIANA is patented solid-phase competitive binding assay that uniquely combines small molecule-based DIANA probes with the strengths of ELISA and qPCR.
Quantitative Results: Determination of quantitative potency data (Kd) from each measurement thanks to the proprietary DIANA technology.
Affordable Excellence: Our service has fast turnaround time and it is possible to fully customize the order. Finally, the pricing makes our top-tier solution accessible to everyone.
Internal Quality Control – Binding potency of known inhibitor is determined for each kinase
Service Information
Name | No. of kinases | Cpds | Price (EUR) | Turnaround time** | Result |
|---|---|---|---|---|---|
DIANA CDK Panel | 24 | 1 | 480 | 7 business days | Kd |
Custom Selection | 1 | 1 | 25* | 7 business days | Kd |
*Minimal Order Quantity for Custom Selection service is 500 EUR.
**Counts from the day compounds are delivered to our testing facility. For complex orders the turnaround time can be extended to 14 business days.
Prices exclude VAT
Related services
Inhibitor Profiling: Kinases
DIANA is a solid-phase competitive binding assay that uniquely combines small molecule-based DIANA probes with the strengths of ELISA and qPCR, delivering robust quantitative potency data with an exceptionally broad dynamic range. This allows researchers to obtain precise binding affinity constants (Kd) from the start of their projects at a cost comparable to conventional methods that only provide relative inhibition.
DB Kinase Panel™
DB Kinase Panel™ is our flagship profiling package, covering over 170 kinases across the entire human kinome. Powered by proprietary DIANA technology, each run delivers true binding constants (Kd) for every kinase making DB Kinase Panel™ the only tool on the market for quantitative potency determination at full kinome scale.
DIANA TK Panel
DIANA TK panel is an advanced tyrosine kinase inhibitor selectivity profiling tool which comprise 69 different TKs. Using proprietary DIANA technology it delivers quantitative affinity measurements (Kd) from single measurement.
DIANA CK1 Panel
DIANA CK1 panel is an advanced CK1 (casein kinase 1) inhibitor selectivity profiling tool which comprise 7 different CK1s. Using proprietary DIANA technology it delivers quantitative affinity measurements (Kd) from single measurement.
DIANA CDK Panel | Collaboration
Write us
